Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]

Development of a risk stratifying prognostic index for ALL

Prof Anthony Moorman - Newcastle University, Newcastle, UK

Development of a risk stratifying prognostic index for ALL ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )

Specification of haematopoetic stem cell fate via modulation of mitochondrial...

Dr Mukul Girotra - Ludwig Center for Cancer Research, Lausanne, Switzerland

Specification of haematopoetic stem cell fate via modulation of mitochondrial activity ( Dr Mukul Girotra - Ludwig Center for Cancer Research, Lausanne, Switzerland )

EHA Topics in focus : Immunotherapy

Prof John Gribben - Barts Cancer Institute, London, United Kingdom

EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )

Updated results from a phase I trial of CAR-T cell therapy for r/rMM

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA

Updated results from a phase I trial of CAR-T cell therapy for r/rMM ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )

Updated data from the FORTE trial of carfilzomib plus lenalidomide or...

Dr Francesca Gay - University of Torino, Torino, Italy

Updated data from the FORTE trial of carfilzomib plus lenalidomide or cyclophosphamide for myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )

Disease control in advanced Hodgkin lymphoma

Dr Olivier Casasnovas - CHU de Dijon, Dijon, France

Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium

Repurposing selective PDE5 inhibitors as anti-cancer agents ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )

First results of DREAM trial of frontline durvalumab for mesothelioma

Prof Anna Nowak - The University of Western Australia, Perth, Australia

First results of DREAM trial of frontline durvalumab for mesothelioma ( Prof Anna Nowak - The University of Western Australia, Perth, Australia )

International cancer control plans

Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana

International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA

Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory...

Dr Ajai Chari - Mount Sinai Hospital, New York, USA

$Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )$

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

More from ecancer